Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

 

RA
54:18

John Tesser

Beyond TNF Blockade: Breakthroughs in Rheumatoid Arthritis Pathogenesis

  • 447 views
  • March 15, 2024
  • 4
20:34

Cleveland Clinic Rheumatology

CVD in RA: Need for Management of CVD in RA, CV Risk Calculation & Management Strategies

FEATURING William Rigby
  • 88 views
  • July 27, 2021
29:07

Cleveland Clinic Rheumatology

RA: Use of Imaging to Predict Transition to RA, the Changing Landscape of TNF-I Tapering, and RA Therapeutics

FEATURING William Rigby
  • 79 views
  • July 27, 2021
20:18

Cleveland Clinic Rheumatology

Red Eye in RA: What Is the Differential Diagnosis in General and in Association With RA? What Questions Should You Ask the Patient? Can You Help Without Involving an Ophthalmologist?

FEATURING James Rosenbaum
  • 19 views
  • September 21, 2020
15:06

Cleveland Clinic Rheumatology

Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? Is There a Need for Salvage Therapies with Rituximab, Tocilizumab, and IVIg? What Is the Best Treatment Approach?

FEATURING Joseph Parambil
  • 129 views
  • September 18, 2020
  • 1
VIDEO

Cleveland Clinic Rheumatology

Interstitial Lung Disease: What Are the Most Important Advances in Classification and Treatment a Rheumatologist Needs to Know?

FEATURING Joseph Parambil
  • 127 views
  • September 18, 2020
10:45

Cleveland Clinic Rheumatology

Connective Tissue Disease-Associated Interstitial Lung Disease: Why Is It Important to Distinguish CTD-ILD and Idiopathic Interstitial Pneumonia? Distribution and Histologic Patterns in CTD-ILD

FEATURING Joseph Parambil
  • 111 views
  • September 18, 2020
  • 1
07:12

Cleveland Clinic Rheumatology

Tapering vs. Continuing Glucocorticoids in RA: Do Autoantibody Levels Change After Achieving LDA/Remission? SEMIRA Study Efficacy and Safety Results

FEATURING Arthur Kavanaugh, John J. Cush
  • 12 views
  • September 3, 2020
05:34

Cleveland Clinic Rheumatology

bDMARDs and nbDMARDs in RA: Is VTE a Clinical Concern in RA?

FEATURING Arthur Kavanaugh, John J. Cush
  • 7 views
  • September 3, 2020
05:59

Cleveland Clinic Rheumatology

Rheumatic Diseases & JAKi Efficacy Results: Is TYK2 Effective in PsA? How Safe Is Filgotinib in RA Patients With IR? What Does the Data Suggest on Upadacitinib & Baricitinib?

FEATURING Arthur Kavanaugh, John J. Cush
  • 24 views
  • September 3, 2020
12:33

Cleveland Clinic Rheumatology

RA & 8 TNFi Biosimilars Efficacy Analysis: Can Multiple bDMARD Switches Impact Clinical Efficacy? Is There an Evidence That RA Mortality Gap is Closing With Improved CVD Outcomes and What is The Impact of Immunomodulating Agents on CVD Risk?

FEATURING Arthur Kavanaugh, John J. Cush
  • 7 views
  • September 3, 2020
07:54

Cleveland Clinic Rheumatology

bDMARDS in RA: Why Do Patients With Low Levels of 1st TNFi Respond Better to 2nd TNFi Compared to Those With Higher Levels?

FEATURING Arthur Kavanaugh, John J. Cush
  • 7 views
  • September 3, 2020
08:31

Cleveland Clinic Rheumatology

Refractory Pain in Early RA: What Are the Alternative Treatment Strategies in These Patients?

FEATURING Arthur Kavanaugh, John J. Cush
  • 7 views
  • September 3, 2020
20:57

Cleveland Clinic Rheumatology

IMIDs & Vaccines Update: What Are the Updated Immunization Recommendations? Which Recently FDA Approved Treatments Should Be Considered?

FEATURING Cassandra Calabrese
  • 690 views
  • August 31, 2020
05:59

Cleveland Clinic Rheumatology

Rheumatology – Oncology: Cases with the Masters

FEATURING Leonard Calabrese, Vamsidhar Velcheti
  • 12 views
  • August 28, 2020
30:39

Cleveland Clinic Rheumatology

T Cell Subsets Overview: Is TH1 Critically Important for Killing Facultative Intracellular Organisms? What Are Clinical Responses in Patient With AD Before and After Dupilumab Treatment?

FEATURING John Looney
  • 139 views
  • August 3, 2020
24:57

Cleveland Clinic Rheumatology

Links Between Chronic Inflammation and Atherosclerotic Disease and Evidence-Based Studies Addressing Systemic Inflammation. What are Available Screening Techniques and Practical Approaches to Treat CV Comorbidities in These Patients?

FEATURING Elaine Husni
  • 546 views
  • July 30, 2020
09:20

Cleveland Clinic Rheumatology

Cardiovascular Risk on RA and PsA Patients: What are the Most Common Cardiometabolic Comorbidities? Do RA Patients Have Similar CVD Risk Compared to Patients With Diabetes?

FEATURING Elaine Husni
  • 293 views
  • July 30, 2020
30:51

Cleveland Clinic Rheumatology

Human Behavior and Immunity – Slowing Aging?

FEATURING Leonard Calabrese
  • 2,114 views
  • July 30, 2020
  • 13
07:40

Cleveland Clinic Rheumatology

Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With Pre-existing Autoimmune Diseases? Do Biomarkers Exist to Help Predict irAEs? Will Immunosuppressive Medications, Previously Used for irAEs Treatment Blunt the Anti-Tumor Response?

FEATURING Cassandra Calabrese
  • 128 views
  • July 30, 2020
  • 1
22:30

Cleveland Clinic Rheumatology

Immune Related Adverse Events from Cancer Immunotherapy: The Role of the Rheumatologist in Caring for Patients Who Develop Rheumatic and Dermatologic Immune Related Adverse Events (irAEs).

FEATURING Cassandra Calabrese
  • 106 views
  • July 30, 2020
VIDEO

Cleveland Clinic Rheumatology

Cases with the Masters Discussion: Vasculitis, Co-morbidities, Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis and Beyond

FEATURING John Looney, Cassandra Calabrese
  • 44 views
  • July 30, 2020
14:45

Cleveland Clinic Rheumatology

Case Review of 40-Year-Old Male HIV-infected Patient With Severe Polyarticular Inflammatory Arthritis: What are The Treatment Options and When to Start on Biologics?

FEATURING John Looney, Cassandra Calabrese
  • 9 views
  • July 30, 2020
41:07

Cleveland Clinic Rheumatology

Cases with the Masters: Clinical Challenges in Rheumatoid Arthritis

FEATURING Leonard Calabrese, Edward Keystone, Arthur Kavanaugh, Iain Mcinnes, Jonathan Kay, John J. Cush
  • 59 views
  • January 23, 2019
18:57

Cleveland Clinic Rheumatology

Targeting the IL1 Family in Autoimmune and Autoinflammatory Diseases

FEATURING John Looney
  • 450 views
  • July 30, 2020
  • 2
50:27

Cleveland Clinic Rheumatology

Biologics Across Immune-Mediated Inflammatory Diseases from the Rheumatology Perspective

FEATURING Arthur Kavanaugh, John J. Cush
  • 74 views
  • January 10, 2019
29:26

Cleveland Clinic Rheumatology

Predicting Outcomes in RA - The Role of Biomarkers

FEATURING Jonathan Kay
  • 38 views
  • January 12, 2019
53:53

Cleveland Clinic Rheumatology

Pre-Rheumatoid Arthritis: Can We Define It and Prevent Its Progression?

FEATURING Michael Holers
  • 81 views
  • January 14, 2019
45:10

Cleveland Clinic Rheumatology

Cytokine Profiles in Health and Disease

FEATURING Iain Mcinnes
  • 12 views
  • January 14, 2019
37:02

Cleveland Clinic Rheumatology

Increased Inflammation and Disease Activity Among Current Cigarette Smokers with RA

FEATURING Ted Mikuls
  • 16 views
  • January 15, 2019
32:24

Cleveland Clinic Rheumatology

IgA Plasmablasts Are Evaluated in Subjects at Risk for Future Rheumatoid Arthritis

FEATURING Leonard Calabrese, Michael Holers
  • 128 views
  • January 15, 2019
  • 1
32:50

Cleveland Clinic Rheumatology

Advances in Rheumatoid Arthritis

FEATURING William Rigby
  • 424 views
  • January 15, 2019
  • 4
16:17

Cleveland Clinic Rheumatology

PPACMAN Update (Rheumatology/Dermatology)

FEATURING Joseph Merola
  • 51 views
  • January 15, 2019
19:34

Cleveland Clinic Rheumatology

Preventing Infections in Patients Treated with Biologics

FEATURING Cassandra Calabrese
  • 515 views
  • January 15, 2019
  • 3
23:36

Cleveland Clinic Rheumatology

Revisiting Anti-TNF 20 Years Later

FEATURING John Looney
  • 87 views
  • January 15, 2019
16:50

Cleveland Clinic Rheumatology

T-Cell and B-Cell (and Other) Targeting in IMIDs

FEATURING Gregg Silverman
  • 40 views
  • January 15, 2019
17:28

Cleveland Clinic Rheumatology

IL6 Targeting

FEATURING Leonard Calabrese
  • 43 views
  • January 15, 2019
24:08

Cleveland Clinic Rheumatology

Tailoring Therapy Based on Disease Duration: Is There A Window of Opportunity?

FEATURING Edward Keystone
  • 23 views
  • January 15, 2019
26:10

Cleveland Clinic Rheumatology

Predicting the Outcome of Treatment De-Escalation or Discontinuation: What Do We Know?

FEATURING Arthur Kavanaugh
  • 214 views
  • January 16, 2019
  • 2
30:39

Cleveland Clinic Rheumatology

Herpes Zoster and the Risk of Stroke in Patients with Autoimmune Diseases

FEATURING Leonard Calabrese, Cassandra Calabrese
  • 72 views
  • January 18, 2019
60:16

Cleveland Clinic Rheumatology

Why Personal Behavior Affects Immune Mediated Inflammatory Diseases

FEATURING Leonard Calabrese
  • 227 views
  • January 23, 2019
21:51

Cleveland Clinic Rheumatology

Anti-Drug Antibodies, Random Drug Levels with Efficacy in Certolizumab Pegol

FEATURING Leonard Calabrese, Meghna Jani
  • 71 views
  • January 18, 2019